Trouble in Your Tank: Causes of Plating Voids, Pre-electroless Copper
Dan’s Biz Bookshelf: ‘Growth Hacker Marketing’
Happy’s Tech Talk #38: Novel Metallization for UHDI
LPKF Opens Biolab for ARRALYZE Technology
December 6, 2021 | LPKFEstimated reading time: 1 minute
In its 45-year history, LPKF has repeatedly developed groundbreaking technologies and opened up new markets in the electronics, research and development, automotive and solar sectors. With ARRALZYE, the technology company has now developed a platform that will enable future customers in the biotechnology and pharmaceutical industries to perform single-cell screenings quickly and efficiently. ARRALYZE combines biomedical research with software and precision technology. The system can thus contribute to the accelerated development of personalized medicine, for example in the field of cancer therapies.
Dr. Robin Krueger is the head of ARRALYZE. He studied chemistry and biochemistry and worked early on with optically switchable proteins in hospital germs. "We know that tumors have individual characteristics and are influenced by genes and other physiological properties. For this reason, no one should get a standard cancer therapy, but one that is tailored to them personally." Krueger and his team of collaborators are convinced that ARRALYZE will make the development of modern medication much more cost-effective, thus enabling the widespread use of personalized medicine.
The recently opened biolab is equipped with specialized equipment for the production and analysis of cell cultures. "The biolab is essential for us to understand the needs and problems of our ARRALYZE customers and to be able to offer practical solutions," says Krueger. "This is what sets us apart from other plant growers in this complex field."
For Britta Schulz, member of the Management Board and head of the Development segment, the development of ARRALYZE technology in less than 3 years is a demonstration to LPKF's unwavering innovative strength. "With our LIDE technology for structuring glass and our expertise in optics, precision engineering and software, we are now bringing a product to market that will set new standards in biotechnology," says Schulz.
The system is thus one more step towards pushing back the previous boundaries of cell biology. The innovative approach of this process qualified ARRALYZE for inclusion in the shortlist of the prestigious Innovation Award 2021 of the State of Lower Saxony.
Share on:
Suggested Items
Kaynes Technology Acquires Canada-Based August Electronics
05/09/2025 | PRNewswireAugust Electronics Inc. is pleased to announce that it has entered into a definitive agreement to be acquired by Kaynes Canada Limited, a wholly owned step-down subsidiary of Kaynes Technology India Limited, a leading Electronics System Design & Manufacturing (ESDM) company. The transaction is expected to close by the end of May 2025, subject to customary regulatory approvals and closing conditions.
LITEON Technology Reports Consolidated April Sales of NT$13.4 Billion Up 27% YoY
05/09/2025 | LITEON TechnologyLITEON Technology reported its April consolidated revenue of NT$13.4 billion. Thanks to the growth from power management in cloud computing, advanced server, and networking, the revenue is up 27% YoY.
Ultrahuman Expands its American Factory’s Manufacturing Capacity
05/09/2025 | GlobeNewswireUltrahuman, a pioneer in health optimization technology, has announced that it’s ramping up its capacity of the Ring AIR. Ultrahuman’s manufacturing facility (UltraFactory) in partnership with SVtronics, a US-based electronics manufacturing business, has been operational in Plano, Texas, since November 2024.
Kyocera Licenses Quadric’s Chimera GPNPU AI Processor IP
05/08/2025 | BUSINESS WIREQuadric announced that Kyocera Document Solutions Inc. (hereinafter: Kyocera) has licensed the Chimera™ general purpose neural processor (GPNPU) intellectual property (IP) core for use in next generation office automation system on-chip (SoC) designs.
Scanfil Boosts Investment in Electronics Manufacturing in the US
05/08/2025 | BUSINESS WIREScanfil is investing in a second electronics manufacturing line in Atlanta, Georgia, USA. The demand for manufacturing electronics in the USA has increased over the past two years and is expected to continue growing.